CEO DATELINE - Business groups: Take medical device tax off life support
CEO DATELINE - Business groups: Take medical device tax off life support
- November 27, 2019 |
- Walt Williams
Several associations are urging federal lawmakers to pull the plug on a medical device tax currently scheduled to be reinstated next year, the news site FierceBiotech reported Monday.
Consider joining CEO Update. Membership gives full access to the latest intelligence on association management, career advancement, compensation trends and networking events, as well as hundreds of listings for senior-level association jobs.
The 2.3% tax on medical devices was created as part of the Affordable Care Act in 2010, but lawmakers have twice passed moratoriums on collecting the tax at the urging of the industry. (The tax was collected from 2013-2015.) However, lawmakers have been reluctant to kill the tax outright, with the revenue estimated at nearly $20 billion over a decade.
The tax will go into effect in 2020 unless legislative action is taken to once again suspend it or eliminate it completely. Some business groups are urging the latter, with the Advanced Medical Technology Association (AdvaMed) being the chief opponent of the policy.
"Every day our industry is creating life-changing innovations that save and improve lives, which means good-paying jobs in communities throughout the country," AdvaMed CEO Scott Whitaker told FierceBiotech. "We can't allow this progress to be threatened with the return of this onerous tax."
The U.S. Chamber of Commerce, the Business Roundtable and the National Association of Manufacturers also urged a "full repeal" of the tax in joint letter to Congress. http://bit.ly/2KTLDvo
CEO Update will resume on Monday, Dec. 2.
MORE CEO DATELINE
- PhRMA to cut funding to opioid addiction treatment group
- Archaeological society bans member from meeting following arrest
- American Medical Association seeks ban on vaping products
- Hospital groups to sue over price transparency rule
- Report: Ad agencies reconsidering 4A's membership
- Generic drug group sues California over ‘pay-for-delay' law